Efficacy and safety of NMDA receptor antagonists augmentation therapy for schizophrenia: An updated meta-analysis of randomized placebo-controlled trials

Yuki Matsuda; Taro Kishi; Nakao Iwata

doi:10.1016/j.jpsychires.2013.09.002

Efficacy and safety of NMDA receptor antagonists augmentation therapy for schizophrenia: An updated meta-analysis of randomized placebo-controlled trials

Psychiatry

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	2018-2020
Number of pages	3
Journal	Journal of Psychiatric Research
Volume	47
Issue number	12
DOIs	https://doi.org/10.1016/j.jpsychires.2013.09.002
Publication status	Published - 12-2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Psychiatry and Mental health
Biological Psychiatry

Access to Document

10.1016/j.jpsychires.2013.09.002

Cite this

@article{3d77c0320ea64013a6bea5e74c1e796d,

title = "Efficacy and safety of NMDA receptor antagonists augmentation therapy for schizophrenia: An updated meta-analysis of randomized placebo-controlled trials",

author = "Yuki Matsuda and Taro Kishi and Nakao Iwata",

year = "2013",

month = dec,

doi = "10.1016/j.jpsychires.2013.09.002",

language = "English",

volume = "47",

pages = "2018--2020",

journal = "Journal of Psychiatric Research",

issn = "0022-3956",

publisher = "Elsevier Ltd",

number = "12",

}

TY - JOUR

T1 - Efficacy and safety of NMDA receptor antagonists augmentation therapy for schizophrenia

T2 - An updated meta-analysis of randomized placebo-controlled trials

AU - Matsuda, Yuki

AU - Kishi, Taro

AU - Iwata, Nakao

PY - 2013/12

Y1 - 2013/12

UR - https://www.scopus.com/pages/publications/84886102138

UR - https://www.scopus.com/pages/publications/84886102138#tab=citedBy

U2 - 10.1016/j.jpsychires.2013.09.002

DO - 10.1016/j.jpsychires.2013.09.002

M3 - Letter

C2 - 24079776

AN - SCOPUS:84886102138

SN - 0022-3956

VL - 47

SP - 2018

EP - 2020

JO - Journal of Psychiatric Research

JF - Journal of Psychiatric Research

IS - 12

ER -

Efficacy and safety of NMDA receptor antagonists augmentation therapy for schizophrenia: An updated meta-analysis of randomized placebo-controlled trials

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this